MXC: $0.023
What We Produce


MGC Pharma operates in several different segments of the Phytocannabinoid-based medicines.

MGC Pharma applies high standards of QA and QC to segments of the Phytomedicine industry, allowing us to meet and exceed Good Manufacturing Practice (GMP) and GACP protocols, globally.  Currently the Company has two Investigational Medicinal Products (IMP) being CannEpil® and CogniCann® along with phytotherapeutics from our Mercury MGC Pharma range and white label products.

Are you in Australia or Brazil?

NoYes